The present invention addresses the problem of providing a therapeutic agent containing mesenchymal stem cells, which is more effective for the treatment of a nerve damage. The present invention provides a therapeutic agent for a nerve damage. The therapeutic agent is a preparation for intravenous administration which contains mesenchymal stem cells and/or cells capable of being differentiated into mesenchymal stem cells, and is used in combination with the application of a stimulus to nerves in a patient, in which the application of a stimulus is carried out during a time period between a time point at which the administration of the therapeutic agent is not carried out yet and a time point at which 6 hours has passed after the administration of the therapeutic agent.

A system for treating a patient comprises a stimulator for stimulating brain tissue, a controller for setting stimulation parameters and a diagnostic tool for measuring patient parameters and producing diagnostic data. The stimulation parameters comprise test stimulation parameters and treatment stimulation parameters. The stimulator delivers test stimulation energy to the brain tissue based on at least one test stimulation parameter and delivers treatment stimulation energy to the brain tissue based on at least one treatment stimulation parameter. One or more treatment stimulator parameters are determined based on the diagnostic data produced by the diagnostic tool The system is constructed and arranged to treat a neurological disease or a neurological disorder. Methods of treating a neurological disease or neurological disorder are also provided.

A stimulation arrangement comprising an induction device having a field generator configured to generate a spatial field, a sensor unit, and a control unit in communication with the induction device and the sensor unit. The field generator of the induction device is configured to be positioned at a human or animal patient such that an inspiration muscular structure of the patient is stimulatable by the spatial field, the sensor unit is configured to be positioned at the human or animal patient to sense a feedback of the respiratory system or the patient, and the control unit is configured to control the induction device to generate the spatial field and to receive a feedback signal from the sensor unit. The control unit is configured to evaluate the feedback signal received from the sensor unit, and to activate the field generator of the induction device when the feedback signal is indicative of an abnormality.

One embodiment provides a method for controlling a microagent in a workspace. The method includes providing a plurality of magnetic sources and generating a rotating gradient magnetic field by activating the plurality of magnetic sources differently such that a driving force is created to drive the microagent towards an aggregation center in the workspace.

An apparatus capable of creating synchronized sound, vibration and magnetic field stimulation, for the purpose of habituating and inhibiting brain function while stimulating the human spiritual energy system, is described. The apparatus comprises an amplifier and transducers built into a comfortable seating arrangement including a support structure and a motion platform. The support structure, such as a chair, rests upon the motion platform, which is adapted to impart three-dimensional motion to the support structure. The apparatus uses layered music to create synchronized sounds, vibrations and magnetic fields.

A magnetic stimulation system may include first and second subsystems. The first subsystem may include a first stimulator, a first coil, and a first processor configured to determine stimulation parameter data for a subject. The second subsystem may include a second stimulator, a headpiece including an identifier and a second coil mounted to a headpiece body at a fixed location, an image recording device, and a second processor configured to: receive first image data for one or more first images of the subject and headpiece; receive, from the image recording device, second image data for one or more second images of the subject and headpiece; determine, using the first and second image data, that the stimulation parameter data corresponds to the subject; determine, using the second image data, that the headpiece corresponds to the subject; and determine, using the second image data, that the headpiece is at a pre-determined position.

Systems, devices, and methods for neurostimulation via vestibular stimulation are described. One example is a device for administering thermal stimulation to an ear canal of a subject. The device may include an earpiece configured to be at least partially insertable into the ear canal of the subject; a thermoelectric device thermally coupled to the earpiece and configured to heat and/or cool the earpiece to thereby heat and/or cool the ear canal of the subject; and a controller configured to administer a selected treatment plan including administering a caloric vestibular stimulation (CVS) stimulus to the ear canal of the subject in a condition-treatment effective amount during a first treatment interval. The treatment plan may be effective to produce a durable improvement in at least one symptom of the condition for a time of at least 1 week following cessation of the administering.

A wound therapy apparatus is disclosed that includes a wound interface securable to a skin surface around a wound bed to form an enclosed space over the wound bed that is fluid-tight. The wound therapy apparatus may include a dressing engaged with the wound interface to contact the wound bed. A spacer may be disposed within the enclosed space proximal of the dressing to define a plenum between portions of the wound interface and a proximal side of the dressing. Gas within the enclosed space may have an O.sub.2 concentration greater than the O.sub.2 concentration in atmospheric air. The dressing may include a hydrophobic material, a hydrophilic material, or a distal layer comprised of silicone having fenestrations therein, in various aspects. The pressure p.sub.0 within the enclosed space may vary over a pressure range P.sub.min≤P.sub.0≤P.sub.max. Related methods of use are also disclosed.

A device for providing a magnetic treatment by evoking muscle contraction by a time-varying magnetic field and providing a RF treatment by heating biological structure. The device may provide a pressure treatment. The device includes an applicator having an RF electrode and a magnetic field generating device. The device may also include a main unit, a human machine interface, and a control unit. The control unit adjusts a signal provided to the RF electrode and creates an RF circuit, and also adjusts the signal provided to the magnetic field generating device and creates a magnetic circuit electrically insulated from the RF circuit. The RF circuit may include a power source and a power amplifier, and the magnetic circuit may include an energy storage to supply the magnetic field generating device with electric current.

Composition and method of regenerating a nerve fiber in a damaged neural tissue of a patient, the method includes: administering an aqueous formulation comprising magnetic particles to the damaged neural tissue in the patient; applying a magnetic field in an orientation which is parallel to the nerve fiber; using the magnetic field for aligning the magnetic particles; forming one or more aligned chains of the magnetic particles in the magnetic field as a scaffold to guide directional growth of regenerating nerve cells; and reconnecting damaged nerve ends in the damaged neural tissue of the patient.